Catalyst Pharmaceutical Inc. — gráfico, cotizaciones y noticias (NASDAQ:CPRX) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Market Capitalization 3.2058 B
Employee 182
Founded 2002
CEO N/A
Website www.catalystpharma.com
Headquarter Delaware, United States
FIGI BBG000GZDC67
Industry Technology

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

3.21 B Capitalización de mercado

Ratio precio/beneficio

13.89

Relación precio/flujo de caja

5.04

Noticias

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD